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ABSTRACT 
Combinatorial libraries continue to play a key role in drug discovery. To increase structural diversity, 
several experimental methods have been developed. However, limited efforts have been performed so far 
to quantify the diversity of the broadly used diversity-oriented synthetic (DOS) libraries. Herein we report 
a comprehensive characterization of 15 bis-diazacyclic combinatorial libraries obtained through libraries 
from libraries, which is a DOS approach. Using MACCS keys, radial and different pharmacophoric 
fingerprints as well as six molecular properties, it was demonstrated the increased structural and property 
diversity of the libraries from libraries over the individual libraries. Comparison of the libraries to existing 
drugs, NCI Diversity and the Molecular Libraries Small Molecule Repository revealed the structural 
uniqueness of the combinatorial libraries (mean similarity < 0.5 for any fingerprint representation). In 
particular, bis-cyclic thiourea libraries were the most structurally dissimilar to drugs retaining drug-like 
character in property space. This study represents the first comprehensive quantification of the diversity 
of libraries from libraries providing a solid quantitative approach to compare and contrast the diversity of 
DOS libraries with existing drugs or any other compound collection. 
 
INTRODUCTION 
Synthetic combinatorial methods have advanced the ability to synthesize and screen large numbers of 
compounds because of improvements made in technology, instrumentation, and library design strategies 
(1).
  
Combinatorial chemistry combined with high throughput and other screening methodologies 
continues to play a key role in drug discovery (1-3).
  
A very successful synthetic method is the „Libraries 
from Libraries’ (LoL) approach (4).   This concept is based on the use of well-established solid-phase 
synthesis methods for the generation of combinatorial libraries combined with the chemical 
transformation of such libraries. The chemical libraries that are generated by this process have very 
different physical, chemical, and biological properties compared to the libraries from which they were 
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derived (4).
  
 As such, LoLs can be regarded as a diversity-oriented synthetic (DOS) approach (5, 6),
  
where multiple scaffolds are generated from the same starting material. Increasing skeletal diversity is 
known to be a very efficient way to increase structural diversity (7).
  
 As opposed to high-throughput 
screening, where often a large number of compounds with different scaffolds are screened, LoL explores 
the bioactivity space around each scaffold of interest in much more detail, by using a large number of 
diversity appendages on every scaffold.  
A number of small molecule libraries have been prepared in our group using the LoL approach. 
These libraries have been used successfully to identify novel compounds across a wide range of 
therapeutic applications (4, 8).
  
 Figure 1 shows the LoLs considered in this study. Each LoL includes five 
individual combinatorial libraries containing the same number of diversity positions, identical side chain 
functionalities at each diversity position, and the same number of compounds. Libraries within each LoL 
differ only in the chemical nature of the central scaffold. 
It is well accepted that the structural diversity of LoLs improves upon the diversity of other 
combinatorial libraries, where the „multidimensional diversity‟ regarding both scaffold and appendages is 
often one of the key contributing factors. However, characterizing the diversity is not an easy task, and 
efforts have been pursued in this regard. One example is in the work of Spandl et al.(7)
  
in which the 
importance of skeletal diversity was stressed. Previously, circular fingerprints have been used to assess 
diversity of compound collections (9).
  
 While in this work overall good discrimination between DOS and 
target-oriented synthesis (TOS) libraries could be observed, the question of how to normalize for library 
size could not be answered completely – smaller libraries often assessed were more diverse, since larger 
libraries nearly necessarily contain repetitive chemical motives. Also, Rolfe et al. recently addressed the 
structural diversity of a number of 17 compounds obtained via a “click, click, cyclize” DOS strategy using 
principal component analysis (PCA) based on BCUT descriptors and principal moment of inertia. The 17 
compounds covered different regions of chemical space (10). 
The goal of this study was to characterize the structural diversity of 15 combinatorial libraries 
organized into three LoLs (Figure 1A-C). The analysis is based on two criteria: structural fingerprints and 
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molecular properties. Thus, the LoL concept reported previously and perceived by chemists as giving rise 
to diverse compounds, is now assessed quantitatively for the first time. It is demonstrated that LoL 
generates molecules truly diverse in both structural and molecular property space. 
This work is organized into four sections. The first section describes the fingerprint-based diversity of 
each combinatorial library and LoL. The second section shows the cross-comparison of the three LoLs 
and the 15 libraries. The third section describes the structural comparison of the 15 libraries with external 
compound collections. Section four compares the compound datasets in terms of molecular properties. 
The approaches presented here are general and can be used to characterize the diversity of other LoLs or 
DOS libraries. 
Figure 1 here 
METHODS 
Data sets. Each LoL contains five individual combinatorial libraries reported previously (Figure 1): 
LoLA = A1 U A2 U A3 U A4 U A5 
LoLB = B1 U B2 U B3 U B4 U B5   
LoLC = C1 U C2 U C3 U C4 U C5 
where LoLA-C are the three libraries from libraries considered in this study. Figure 1A shows the bis-
heterocyclic LoLA that includes bis-cyclic diketopiperazines A1, bis-cyclic piperazines A2, bis-cyclic 
guanidines A3, bis-cyclic ureas A4 and bis-cyclic thioureas A5 (8, 11, 12).
  
 LoLB (Figure 1B) is 
composed of bis-cyclic diketopiperazines B1, bis-cyclic piperazines B2, bis-cyclic guanidines B3, bis-
cyclic ureas B4 and bis-cyclic thioureas B5 (8, 13).
  
 LoLC (Figure 1C) includes different pentaamines 
and pyrrolidine bis-heterocyclic libraries, such as pyrrolidine bis-diketopiperazine C1, pyrrolidine bis-
piperazine C2, pyrrolidine bis-cyclic guanidines C3, pentaamine C4 and pyrrolidine bis-cyclic thiourea 
C5 (14).  To note, libraries with the core scaffolds of LoLC and LoLB were screened in a -opioid 
receptor binding assay (1).
  
 The most active libraries had the scaffolds of B3 and C3 (1)
 
 and several 
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compounds of C3 had a Ki lower than 100 nM (1).
  
 Combinatorial libraries with the core scaffold of 
LoLC were recently screened for antitubercular activity leading to compounds with 90–100% inhibition 
against M. tuberculosis at concentrations less than 6.25 g/mL (14).
  
 
 Libraries A1-A5 and B1-B5 have three diversity positions, and C1-C5 have four diversity positions. 
To enumerate libraries A1-A5 and B1-B5, we used ten amino acids or carboxylic acids as building blocks 
for each diversity position. Thus, the size of each individual combinatorial library was 10 x 10 x 10 = 
1,000 compounds; hence LoLA and LoLB contained 5,000 structures each. In order to measure the effect 
of each core template in the diversity, the same set of ten amino acids or carboxylic acids was considered 
for each library. To enumerate C1-C5, we selected six amino acids and five carboxylic acids from the 
pool of the ten building blocks used in the libraries above. Thus, the size of each library C1-C5 was 6 x 6 
x 6 x 5 = 1,080 compounds, and LoLC contained 5,400 structures. A complete list of the building blocks 
used to enumerate the libraries is in Table S1 of the Supporting information. In order to compare the 
diversity across different libraries, we considered approximately the same library size; i.e., 1,000 – 1,080 
compounds. In addition, it has been reported that data sets of 1,000 molecules are representative samples 
to study the structural diversity of combinatorial and other libraries (15, 16).
  
 The combinatorial libraries 
were enumerated using the QuaSAR-CombiDesign module of the Molecular Operating Environment 
(MOE) program, version 2009.10 (17).
  
 The collection of drugs (1,490 compounds) was obtained from 
DrugBank (18) as collected in the ZINC database (download July 2008) (19).
  
 The NCI diversity set 
(1,832 compounds with unique SMILES as computed with MOE) was obtained from ZINC (download 
March 2010). The MLSMR collection was obtained from PubChem (20) (347,480 compounds 
downloaded in May 2010) and processed with MOE by disconnecting group I metals in simple salts and 
keeping the largest fragment. 
Comparison metrics. Compound collections were analyzed based on structural fingerprints and 
molecular properties. Similarity values were computed using the 2D fingerprints MACCS keys (21) (166 
bits), graph-based three point pharmacophores (GpiDAPH3), typed graph distances (TGD) implemented 
in MOE, and radial fingerprints (equivalent to ECFP4) implemented in Canvas (22).
  
 In addition, we used 
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the 3D fingerprint spatial three-point pharmacophore (piDAPH3) from MOE, calculated from the 
structures geometrically optimized using the MMFF94x force field implemented in MOE. The Tanimoto 
coefficient (23, 24) was used as the similarity measure for all fingerprints. 
Intra-library similarity. Pairwise similarities were computed for each combinatorial library. The 
distribution of similarities was analyzed by means of cumulative distribution function (CDF) curves. 
Inter-library similarity. LoLs were compared to each other computing the pairwise structural similarity. 
To this end, we employed random samples of 300 compounds per library so that each LoL contained 
1,500 members (25).
 
 The pairwise similarities were analyzed using CDF curves and multi-fusion 
similarity (MFS) maps. The MFS map is a method developed recently for the visual characterization and 
comparison of compound databases and is based on data-fusion similarity measures. The fusion data are 
plotted in two dimensions, where the ordinate represents the maximum-fusion values and the abscissa the 
mean-fusion values. Each point in the map is associated with a specific molecule in the test set, and its 
position is determined by the corresponding fusion values computed with respect to the molecules in the 
reference set (26).
  
 The MFS maps can be characterized quantitatively by the corresponding distributions 
of the max- and mean-fusion values (27).
  
 This approach has been employed to explore structure-activity 
relationships of compounds data sets (28) and to compare combinatorial libraries (16, 27, 29).
  
 
Comparison with external compound collections. The 15 libraries, with 1,000 (A1-A5, B1-B5) and 1,080 
(C1-C5) molecules each, were compared with a collection of drugs, the NCI Diversity set and the 
Molecular Libraries Small Molecule Repository (MLSMR) using MACCS keys, GpiDAPH3, TGD and 
piDAPH3 fingerprints. We employed MFS maps (setting the external compound collections as the 
reference sets) and Latent Trait Mapping (LTM) plots. LTM is a dimensionality reduction technique that 
is specially designed to visualize discrete data (30).
 
  It defines a function (or mapping) from the original 
data space to a lower-dimension (usually 2D) visualization space.  Because the mapping is non-linear, it 
often provides a more informative visualization than either plotting pairs of the original variables (such as 
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MFS maps) or linear maps (such as PCA).  The price to pay for the greater insight is that there is no 
interpretation of the axes on the visualization plot. 
Molecular properties and property space. The following properties were computed with MOE molecular 
weight (MW), number of rotatable bonds (RB), hydrogen bond acceptors (HBA), hydrogen bond donors 
(HBD), topological polar surface area (TPSA), and the octanol/water partition coefficient (SlogP). To 
obtain a visual representation of the property space (27),
  
 PCA was carried out in Spotfire 9.1.2 (31) 
considering the six molecular properties and plotting the first two principal components. 
RESULTS AND DISCUSSION 
Intra-library diversity 
Figure 2 summarizes the distribution of similarities of LoLA, LoLB and LoLC and the corresponding 
individual libraries using MACCS keys. Figure 2A shows a comparison of the diversity of LoLA and A1-
A5. The CDFs and the corresponding statistics indicate that LoLA is more diverse than each individual 
library. For example, compare the median and mean of the similarity distribution of LoLA (0.627 and 
0.641, respectively) with the corresponding values for the individual libraries (≥ 0.786 and ≥ 0.789, 
respectively). Also, compare the standard deviation of LoLA (0.110) with the standard deviation of A1-
A5 (≤ 0.08). The CDFs also indicated that A3 and A5 showed slightly higher diversity than A1, A2 and 
A4. Library A1 showed the lowest diversity. 
Figure 2 here 
 Figure 2B and 2C summarize the distribution of similarities of LoLB and LoLC, respectively, along 
with their corresponding individual libraries. LoLB and LoLC have higher diversity (lower similarity) 
than their corresponding libraries. Bis-cyclic diketopiperazine libraries (B1 and C1), had lower diversity 
as compared to other corresponding individual libraries within the same LoL. To note, a relatively small 
pre-defined MACCS keys (166 bits) was sufficient to differentiate between the libraries. These results 
suggest that MACCS keys could focus only on the discriminant features but neglect other relevant 
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chemistry. However, we obtained similar conclusions using other structural representations including 
TGD, GpiDAPH, radial and piDAPH3 fingerprints (see below). 
 
Inter-library diversity 
Figure 3 shows the heat maps of similarity matrices of the 15 combinatorial libraries calculated with 
MACCS, TGD, GpiDAPH, radial and piDAPH3 fingerprints. Each map visualizes 1,500 x 1,500 = 
2,250,000 pairwise comparisons and is color-coded by similarity value using a continuous scale from 
green (low similarity value) to red (high similarity value). The name of the individual libraries and LoLs 
are indicated in the figure. Each map can be divided into 15 x 15 = 225 “minor” regions or squares that 
correspond to the pairwise comparison of all 15 libraries. The maps can also be divided into 3 x 3 = 9 
“major” regions that are associated with the cross-comparisons of LoLA, LoLB and LoLC. The minor or 
major regions along the main diagonals starting from the top-left correspond to the self-library 
comparisons. The maps help to visually inspect the similarity between individual libraries that belong to 
the same LoL as well as to different LoLs. In general, in this study most of the similarity values computed 
with radial fingerprints were close to zero. TGD, piDAPH3 and GpiDAPH3 showed comparable 
similarity relationships among databases although with different scales; similarity values calculated with 
TGD were higher than the similarities calculated with piDAPH3 and GpiDAPH3. Noteworthy, the 
pharmacophoric fingerprints, TGD, piDAPH3 and GpiDAPH3, were unable to distinguish the pair of 
libraries A4-A5 or B4-B5. This is because the difference in the central scaffold of these libraries is an 
oxygen (A4-B4) or sulphur atom (A5-B5) that are treated as equal by TGD, piDAPH3 and GpiDAPH3. 
MACCS keys provided very insightful results and were able to distinguish all libraries; therefore, we will 
mainly focus on MACCS keys to discuss the inter-library similarity. 
Figure 3 here 
Along the main diagonal on the heat map based on MACCS keys (Figure 3), there are 15 black-to-red 
squares indicating a high similarity for the self-individual library comparisons; e.g., comparison of A1-
A1, A2-A2, A3-A3, A4-A4, B1-B1. In contrast, the three major regions along the main diagonal (self-
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LoL comparisons, LoLA-A, LoLB-B, LoLC-C), contain a number of green and black-to-green squares; in 
particular, LoLA-A and LoLB-B. This observation suggests a low similarity between the five individual 
libraries that belong to the same LoL. The visual analysis of the similarity matrix of random samples is in 
agreement with the increased diversity of each LoL as compared to the individual libraries (see above). A 
quantitative analysis of each major quadrant is discussed later in this section. 
A diagonal of black-to-red squares can be identified in the major region associated with the cross-
comparisons of LoLA-B. This diagonal indicates the high similarity between individual libraries that 
belong to different LoLs; for example, A1-B1, A2-B2, A3-B3, A4-B4 and A5-B5. This is because all 
these pairs of libraries have a bis-cyclic heterocyclic ring in common, namely, bis-cyclic 
diketopiperazines (A1, B1), bis-cyclic piperazines (A2, B2), bis-cyclic guanidines (A3, B3), bis-cyclic 
ureas (A4, B4) and bis-cyclic thioureas (A5, B5). Similar conclusions are obtained from the cross-
comparisons LoLA-C and LoLB-C. Note, however, that the A4-C4 and B4-C4 comparisons are green-to-
black indicating lower similarity. This observation is associated with the different scaffold of A4 and B4 
(bis-cyclic urea), and C4 (pentaamine). To note, the black-to-red square comparing libraries B3-C3 
indicates high similarity between these collections. To note, both libraries have a bis-cyclic guanidine 
moiety in the central scaffold, and libraries with these scaffolds were the most active in a -opioid 
receptor binding assay (1).
 
 The heat map calculated using MACCS keys also provides a quick inspection 
of the more diverse libraries; for example, the green squares corresponding to the pair of libraries A1-B3 
and A5-B1 indicate low similarity. 
The heat map of similarity matrices is a simple and powerful tool to explore structural relationships 
between LoLs and the individual libraries. The visual analysis was expanded with a quantitative study of 
the similarities between LoLs. Figure 4 shows the CDFs and corresponding statistics of the distribution of 
the MACCS pairwise similarities comparing the LoLs. The CDFs for the self-LoL comparisons with 300 
compounds per library are similar to the CDFs for the self-LoL comparisons with 1,000 (LoLA, LoLB) 
and 1,080 compounds (LoLC) per library. This result suggests that the random samples with 300 
compounds per library are representative. The CDF curves indicate that each of the LoL is structurally 
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diverse. Figure 4 shows that LoLA is the most diverse of the three LoLs, whereas LoLC is the least 
diverse. This result agrees with the conclusions obtained from the heat map in Figure 3 and CDFs in 
Figure 2A. The CDF for the cross-LoL comparisons (Figure 4) indicate the low similarity between any 
pair of LoLs. The pair LoLA-B has the highest diversity, whereas the pair LoLB-C has the lowest 
diversity. Similar conclusions were derived from the heat map (Figure 3). 
Figure 4 here 
Figure 5 depicts the MFS maps comparing the LoLs with themselves (self-reference) and with other 
LoL (cross-comparisons) using MACCS keys. The reference sets are designated along the top and the test 
sets along the left-hand side of the figure. The three maps along the main diagonal are self-referential. In 
all maps the mean similarity ranges within similar values (~0.5 < mean similarity < ~0.75) indicating 
comparable diversity of the reference sets. This result is in agreement with the similarity distributions of 
the three LoLs (Figure 2 and 4). Concerning the self-referential MFS maps, the maximum values are high 
(> 0.9 and several > 0.95) indicating that each molecule in the corresponding LoL has a close nearest-
neighbor (expected to belong to the same individual library). However, the corresponding mean values are 
lower than 0.75 indicating the higher diversity of the corresponding LoL. 
Figure 5 here 
The MFS maps along the left-hand side of Figure 5 show the relationship of LoLB and LoLC to 
LoLA (reference). LoLB has larger maximum values than LoLC indicating that LoLB has closer 
neighbors in LoLA. This result is difficult to deduce from the heat maps in Figure 3. The MFS maps 
along the center of Figure 5 show the relationship of LoLA and LoLC to LoLB (reference) suggesting a 
similar relationship between the two LoLs and LoLB. The MFS maps along the right-hand side of Figure 
5 depict the relationship of LoLA and LoLB with LoLC indicating an overall lower similarity of LoLA 
(32).
 
 
 
Structural comparison with external data sets 
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Figure 6 shows the MFS maps and the corresponding CDFs of the maximum- and mean-fusion values 
comparing the relationship between LoLA-C (test) and drugs (reference) using MACCS keys. The CDF 
of the maximum-fusion values are reminiscent of the nearest-neighbors curves (33, 34).
 
 These maps 
suggest that there are no identical compounds between any of the combinatorial libraries and drugs; 
moreover, all the compounds in the combinatorial libraries have a maximum MACCS keys similarity 
lower than 0.9 to any of the drugs and most of the compounds have maximum similarity lower than 0.85. 
Note also the larger distribution of the molecules in each of the three MFS maps considering the entire 
LoLs as compared to the distribution of the molecules of each combinatorial library. This result further 
supports the increased diversity of LoLs over the individual libraries. Similar conclusions were obtained 
with other fingerprint representations (see below). 
Figure 6 here 
Figure 6A shows the MFS maps and CDF for libraries A1-A5. A1 is towards the top right part of the 
MFS map suggesting a relative increased structural similarity to drugs as compared to A2-A5. This 
observation was further confirmed by the CDFs of the maximum- and mean-fusion values. A5 is located 
towards the bottom left part of the MFS map suggesting that this library is the least similar to drugs. A 
similar conclusion can be derived from the CDFs. Note, however, that the CDF of the mean-fusion value 
cannot distinguish A3 and A5 since these two libraries have the same mean similarity relationship to 
drugs. A2 and A4 are, in general, the second most similar libraries to drugs after A1 as suggested by the 
MFS map. To note, the corresponding CDFs of the maximum- and mean-fusion values indicate an 
opposite order of similarity for A2 and A4 with respect to drugs; the CDF of the maximum-fusion values 
for library A2 is shifted towards higher values than the corresponding curve for A4 indicating that the 
nearest neighbors of A2 in DrugBank are closer that the nearest neighbors for A4. However, the CDF of 
the mean-fusion values for library A4 is shifted towards higher values indicating that, on average, A4 is 
more similar to drugs than A2. These observations highlight the importance of considering more than one 
metric for a complete assessment of the relationship between compound collections. 
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Figure 6B shows the MFS maps and CDFs for libraries B1-B5. According to the MFS map B1, a bis-
cyclic diketopiperazine library (related to A1), is structurally more similar to drugs as compared to other 
libraries within LoLB. Library B5, a bis-cyclic thiourea (related to A5), is the less similar to drugs. 
Similar conclusions can be derived from the CDFs. The CDFs of the maximum- and mean-fusion values 
for B2 and B4, respectively, indicate that while B2 has closer nearest neighbors in the collections of 
drugs, B4 is on average more similar to drugs. Figure 6C shows the MFS maps and CDFs for C1-C5 
indicating that the pyrrolidine bis-cyclic thioureas C5 are the less structurally similar to drugs. According 
to the MFS map and CDF of the mean-fusion values, pyrrolidine bis-cyclic diketopiperazines C1 are 
more similar to drugs as compared to other libraries within LoLC. To note, the CDF for the maximum-
fusion values indicates that C1 and C2 have a similar nearest-neighbor relationships to drugs; however, 
C1 is on average structurally more similar to drugs than C2. 
Figure 7 depicts a visualization of the chemical space comparing LoLs and drugs using the LTM 
algorithm with MACCS keys (166 bits) as the molecular descriptors (35).
 
 The binary (0-1) data is well 
suited to this algorithm.  Figure 7A shows LoLA, LoLB, LoLC and drugs in the same space. For clarity, 
Figure 7B-D show a comparison of the chemical space of drugs with each LoL, respectively, within the 
same coordinates as Figure 7A. The LTM plots on the left-hand side of Figure 7B-D shows the LoL as 
one color, whereas the chemical space on the right-hand side shows each individual combinatorial library 
with different colors (color scheme as in Figure 1). Visualization of the chemical space in Figure 7B-D 
shows that LoLA-C cover a larger area of the chemical space than the space covered by each 
combinatorial library. This result supports the increased structural diversity of the LoLs over the 
individual libraries. 
Figure 7 here 
Visualization of the chemical space with the LTM plots shows different relationships of A1-A5, B1-
B5 and C1-C5 with drugs. As such, libraries with a bis-cyclic guanidine moiety in the core scaffold A3, 
B3, C3 (in black), and with a bis-cyclic urea moiety A5, B5 and C5 (in yellow) are the most dissimilar to 
drugs. In contrast, libraries containing a diketopiperazine moiety A1, B1 and C1 (in blue) are the most 
 13 
structurally similar to drugs. Measuring the mean distance of drugs to each library in the LTM space 
further confirmed these conclusions (Table S3 of the Supporting information). Note, however, that there 
are no overlaps in the structural MACCS keys space between the combinatorial libraries and drugs. These 
results are in agreement with the MFS maps and CDF curves discussed above (Figure 6). In contrast to 
MFS maps, LTM plots enable the visualization of the reference set (i.e., drugs) in chemical space.  It is 
also noteworthy that the LTM plots show the separation between different classes much better than the 
MFS maps (and the PCA visualizations discussed below and shown in Figure 8). In addition, the 
relationships between different libraries (as measured by distance in the LTM space) are better defined, 
and there is more information about the groupings of compounds within each library. Further interactive 
exploration of these visualizations can be carried out using the Data Visualization and Modeling System 
(DVMS) tool (35, 36).  
We also analyzed the structural relationship between LoLs and NCI diversity using the MFS maps 
and CDFs using MACCS keys (plots not shown). Similar to the comparison with drugs, the combinatorial 
libraries showed a different structural relationship to NCI diversity. It was also concluded that there are no 
identical molecules between NCI Diversity and any combinatorial library. Moreover, most of the 
compounds in any combinatorial library have maximum MACCS keys similarity of 0.80. Lower 
similarity values were computed with other fingerprint representations (see below). 
Since the chemical space depends on the molecular representation (37),
  
we investigated the structural 
relationship of the LoLs to drugs, NCI diversity and MLSMR using TGD, GpiDAPH3 and piDAPH3 
fingerprints. For MLSMR, a subset of 3,000 compounds was selected at random. The maximum- and 
mean-fusion values (Table S4 of the Supporting information), confirmed that the combinatorial libraries 
are structurally different from drugs, NCI diversity and MLSMR regardless of the structural 
representation. 
 
Property Diversity 
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Table 1 summarizes the median, mean and standard deviation of the distribution of the six molecular 
properties described in Methods for the 15 libraries, three LoLs and external data sets. Additional 
statistics of the distributions (e.g., maximum, minimum, first and third quartile and U95 and L95 values) 
are presented in Table S2 of the Supporting information. The three important molecular properties of size, 
flexibility and molecular polarity are described by MW; RB; and SlogP, TPSA, HBA and HBD, 
respectively. The six descriptors used here have been used to compare the property space covered by a 
virtual collection and reference databases (38) and other combinatorial libraries (16).
  
 According to Table 
1 and Table S2 of the Supporting information, each LoL has a wider distribution of molecular properties 
than their corresponding individual libraries as reflected by the larger standard deviation and range for 
most of the properties. Since all of the combinatorial libraries within a LoL contain the same number of 
diversity positions, identical side chain functionalities at each diversity position, and the same number of 
compounds with the library (see above), the variation in the properties within a LoL is due to the central 
scaffold. These results further demonstrate the observation that increasing skeletal diversity is a very 
efficient way to increase not only the structural diversity (7),
 
but also property diversity. 
Table 1 here 
 According to Table 1 and S2, LoLA and the corresponding individual libraries have, in general, more 
HBA, HBD, and larger TPSA values than drugs. The number of rotatable bonds in any of the libraries in 
LoLA is quite similar to the number of RB in drugs. Also, LoLA has a distribution of SlogP values 
comparable to drugs; in particular A4 and A5.  In general, LoLB and the corresponding individual 
libraries have larger SlogP, MW and RB values than drugs. B4, B3 and B5 have a distribution of HBA 
and HBD comparable to drugs (B3 also has a similar distribution of TPSA values). LoLC has, in general, 
larger values of HBA, RB and MW than drugs. C1, C2 and C5 have a distribution of HBD comparable to 
drugs (C1 also has similar distribution of SlogP values and C4 a similar distribution of TPSA values). 
In order to generate a visual representation of the property space, the six molecular properties were 
subjected to PCA after Z-scaling. Figure 8 depicts an approximation of the property space as defined by 
these properties. The first two principal components (PC) with eigenvalues 2.172 and 2.071, respectively, 
 15 
account for 70.71% of the variance. (Components with eigenvalues less than 1.0 were not considered).  
Figure 8A shows LoLA, LoLB and LoLC, drugs and NCI Diversity sets in the same space. From this 
figure and the property distributions (Tables 1 and S2), it can be concluded that NCI diversity covers a 
similar region of the property space occupied by drugs. For the sake of clarity, Figures 8B-D show a 
comparison of the property space of drugs with each LoL, respectively, within the same coordinates as 
Figure 8A. The property space on the left-hand side of Figures 8B-D show the LoL is one color, whereas 
the property space on the right-hand side shows each individual combinatorial library with different colors 
(color scheme as in Figure 1). Table 2 summarizes the corresponding loadings and eigenvalues for the six 
PCs. For the first PC, the larger loadings correspond to MW followed by RB. For the second PC, the 
largest loading corresponds to HBD followed by TPSA, whereas for the third PC, the largest loading 
corresponds to TPSA followed by HBA. Figures 8B-D reveal that LoLA, LoLB and LoLC cover a larger 
area of the property space than the space covered by each individual library. This observation further 
demonstrates the increased property diversity of the LoLs over the individual combinatorial libraries. 
Figure 8 here 
Table 2 here 
Figures 8B-D also show a different degree of overlap between LoLs and drugs. LoLA has a 
significant overlap with drugs (Figure 8B). Noteworthy, LoLA is structurally dissimilar to drugs (see 
above). In other words, the chemical structures of LoLA are different from the structures of drugs; 
however, the molecular properties of LoLA are similar to the properties of drugs. This observation 
illustrates the dependence of chemical space with the structural representation (37) and further 
emphasizes the importance of considering multiple criteria when comparing compound data sets (39, 40). 
LoLB and LoLC cover regions of the property space sparsely populated by drugs (Figures 8C and 
8D, respectively). A major difference in the distribution of LoLB, LoLC and drugs occurs along the 
coordinates of the first PC that is mainly associated with MW and RB. These results are in agreement 
with the conclusions derived from the property distributions in Tables 1 and S2. The areas in the property 
space with few drugs represent areas that are biologically relevant as revealed by the presence of some 
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drugs but may not have been sufficiently explored (16).
 
In addition, LoLB and LoLC sample unexplored 
regions of the drug space. Coverage of regions unexplored by drugs has been reported for other DOS and 
combinatorial libraries (16, 41). Molecules in these areas, while potentially unlikely to make drugs by 
themselves, are valuable as chemical probes in order to better understand the structure-activity 
relationships associated with unknown targets (9, 16).
 
 Although the LTM (Figure 7) and PCA plots 
(Figure 8) represent visual approximations of the property space, they provide a useful idea of the 
molecules‟ distribution in the space.  The non-linear nature of the LTM means that it provides greater 
discrimination between libraries and also within each library. 
We also compared the property space of the LoLs with MLSMR using the same random subset 
employed in the structural study (42).
 
 A visualization of the property space is depicted in Figure S2. (The 
corresponding loadings and eigenvalues are summarized in Table S5 of the Supporting information). We 
concluded that LoLA, LoLB and LoLC not only occupy part of the property space of MLSMR but also 
sparse regions. 
The major focus of this study was to demonstrate quantitatively the increased diversity of the 
combinatorial libraries generated with the LoL approach. To this end, we considered a standard set of 
building blocks for each LoL enumerating ~1000 compounds per library. Note, however, that the actual 
size of the libraries can be much larger. For example, libraries with the pyrrolidine bis-cyclic scaffolds 
have been synthesized and screened with 738,192 compounds per library. Similarly, libraries with the bis-
cyclic scaffolds have been synthesized and screened with 45,864 compounds per library (1).
  
 
CONCLUSIONS AND PERSPECTIVES 
Herein we report a comprehensive characterization of the diversity of 15 combinatorial libraries obtained 
with the libraries from libraries (LoLs) approach. The 15 libraries are grouped in three bis-diazacyclic 
LoLs. Previous studies showed that several of the central scaffolds considered in this study are 
biologically relevant. Structural fingerprints, including MACCS keys, GpiDAPH3, TGD, radial and 
piDAPH3 fingerprints, as well as molecular properties, were considered to assess the diversity. Analysis 
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of the structural diversity of the libraries showed that the LoLs are more diverse than the corresponding 
individual libraries. Distributions of pairwise structural similarities and heat maps of similarity matrices 
revealed that libraries within the same LoL are structurally diverse, mainly combinatorial libraries in 
LoLA followed by libraries in LoLB. All these results provide quantitative measures of the different 
chemical and physical properties of the libraries generated by the LoL approach. Fingerprints-based 
comparisons indicated that the 15 libraries are structurally different from drugs, NCI Diversity and 
MLSMR. MFS maps and LTM plots revealed that libraries containing a bis-cyclic thiourea moiety in the 
central scaffold (A5, B5 and C5) are the most structurally dissimilar to drugs. In contrast, libraries with a 
bis-cyclic diketopiperazine moiety in the central scaffold (A1, B1 and C1) are more structurally similar to 
drugs. Comparison of the libraries with drugs using molecular properties showed that combinatorial 
libraries have a different degree of overlap with the property space of drugs. In particular, despite the fact 
that LoLA is structurally dissimilar to drugs, their properties are similar. 
Focused and targeted combinatorial libraries have gained an increased interest in recent years (43-
45).
 
 The core scaffolds presented here represent potential starting points of focused or targeted 
combinatorial libraries. The most suitable core scaffold(s) for a particular target family can be explored 
using computer-aided target fishing approaches (46, 47)
  
and in-silico “scaffold ranking” (1) to identify 
the most promising core scaffolds for a particular target or target family before synthesis. 
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Figure 1  Fifteen combinatorial libraries organized into three libraries from libraries (LoL) analyzed in 
this study. Each library within a LoL shares the same number of diversity positions, identical building 
block side chain functionalities, and the same number of compounds within each library 
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Figure 2  Intra-libraries similarities using MACCS keys. Figure shows the cumulative distribution 
function (CDF) of pair-wise similarities for each library and LoL. CDF for each library indicates the 
distribution of 499500 pairwise-comparisons taken from the similarity matrix. The CDF for the LoLs also 
contains 499500 points taken at random from the entire similarity matrix. (See also Figure 3 and text for 
discussion) 
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Figure 3  Heat maps of similarity matrices comparing 15 libraries (300 compounds at random per library) 
using different fingerprints, 2D (MACCS, TGD, GpiDAPH3 and radial) and 3D (piDAPH3). Similarity is 
colored using a continuous color scale from red (high similarity) to green (low similarity) 
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Figure 4 Cumulative distribution functions of the MACCS keys pairwise similarities between the LoLs 
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Figure 5  Multi-fusion similarity maps comparing the relationship of the LoLs. The reference LoLs are 
designated along the top and the test LoLs along the left-hand side of the figure. The three plots along the 
principal diagonal (upper left to lower right in the figure) correspond to self-referencing MFS maps. 
LoLA is in brown squares, LoLB in orange circles and LoLC in violet triangles 
 
 
LoLA 
LoLB C 
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Figure 6 Relationship between a collection of drugs (reference) with the following test compounds: (A) 
libraries A1-A5, (B) libraries B1-B5 and (C) libraries C1-C5. MFS maps and the corresponding CDF of 
the maximum and mean values distributions are shown 
LoLB 
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Figure 7 LTM plots of three LoLs, 15 combinatorial libraries and drugs. (A) Drugs (gray), LoLA 
(brown), LoLB (orange) and LoLC (purple); (B) drugs and LoLA (left), drugs and A1-A5 (right); (C) 
drugs and LoLB (left), drugs and B1-B5 (right); (D) drugs and LoLC (left), drugs and C1-C5 (right). A1-
A5, B1-B5, C1-C5 are color- and shape-coded as in Figures 1, 5 and 6 
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Figure 8 Property space of three LoLs, 15 combinatorial libraries, drugs (gray) and NCI diversity (pink). 
The first two PC account for 70.71% of the variance. The loadings are summarized in Table 2. (A) Drugs, 
LoLA, LoLB, LoLC and NCI Diversity; (B) drugs and LoLA (brown) and drugs and A1-A5; (C) drugs 
and LoLB (orange) and drugs and B1-B5; (D) drugs and LoLC (purple) and drugs and C1-C5. A1-A5, 
B1-B5, C1-C5 are color coded as in Figures 1, 5 and 6 
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Table 1. Distribution of molecular properties 
 
Library 
HBA   HBD   RB 
Median Mean StdDev  Median Mean StdDev  Median Mean StdDev 
LoLA 4.00 3.70 1.26  3.00 3.30 1.13  6.00 6.30 1.21 
A1 5.00 4.90 0.79  3.00 2.90 0.79  6.00 6.30 1.21 
A2 5.00 4.90 0.79  3.00 2.90 0.79  6.00 6.30 1.21 
A3 3.00 2.90 0.79  5.00 4.90 0.79  6.00 6.30 1.21 
A4 3.00 2.90 0.79  3.00 2.90 0.79  6.00 6.30 1.21 
A5 3.00 2.90 0.79  3.00 2.90 0.79  6.00 6.30 1.21 
LoLB 3.00 3.10 1.08  1.00 1.70 0.92  11.00 11.10 1.18 
B1 4.00 4.30 0.46  1.00 1.30 0.46  11.00 11.10 1.18 
B2 4.00 4.30 0.46  1.00 1.30 0.46  11.00 11.10 1.18 
B3 2.00 2.30 0.46  3.00 3.30 0.46  11.00 11.10 1.18 
B4 2.00 2.30 0.46  1.00 1.30 0.46  11.00 11.10 1.18 
B5 2.00 2.30 0.46  1.00 1.30 0.46  11.00 11.10 1.18 
LoLC 5.00 4.70 1.17  2.00 2.50 1.42  11.00 11.90 2.38 
C1 5.00 5.50 0.65  1.00 1.50 0.65  11.00 10.90 1.29 
C2 5.00 5.50 0.65  1.00 1.50 0.65  11.00 10.90 1.29 
C3 3.00 3.50 0.65  3.00 3.50 0.65  11.00 10.90 1.29 
C4 5.00 5.50 0.65  4.00 4.50 0.65  16.00 15.90 1.29 
C5 3.00 3.50 0.65  1.00 1.50 0.65  11.00 10.90 1.29 
DrugBank 2.00 2.46 1.69  1.00 1.18 1.22  5.00 5.07 3.26 
NCI Diversity 2.00 2.70 1.64  1.00 1.36 1.19  3.00 3.39 2.14 
MLSMR(3000) 4.00 3.72 1.82  1.00 1.07 1.03  7.00 6.71 3.48 
MLSMR(347480) 3.00 3.35 1.49  1.00 1.07 0.90  6.00 6.16 2.90 
            
 
SlogP   TPSA   MW 
Median Mean StdDev  Median Mean StdDev  Median Mean StdDev 
LoLA 1.13 1.02 1.70  98.47 91.61 29.42  360.55 363.30 57.56 
A1 -0.58 -0.63 1.47  119.05 117.03 16.07  402.45 402.07 52.71 
A2 1.31 1.26 1.47  50.77 48.75 16.07  346.52 346.14 52.71 
A3 1.18 1.13 1.47  98.47 96.45 16.07  344.46 344.08 52.71 
A4 1.55 1.50 1.47  84.91 82.89 16.07  346.43 346.05 52.71 
A5 1.88 1.83 1.47  114.95 112.93 16.07  378.57 378.18 52.71 
LoLB 3.99 3.86 1.32  76.12 70.68 26.34  448.70 450.68 45.33 
B1 2.31 2.21 1.00  90.03 96.10 9.28  488.67 489.45 38.97 
B2 4.21 4.11 1.00  21.75 27.82 9.28  432.74 433.52 38.97 
B3 4.08 3.98 1.00  69.45 75.52 9.28  430.69 431.46 38.97 
B4 4.45 4.35 1.00  55.89 61.96 9.28  432.65 433.43 38.97 
B5 4.78 4.68 1.00  85.93 92.00 9.28  464.79 465.56 38.97 
LoLC 2.98 2.96 1.72  85.63 79.21 27.62  487.78 487.39 60.97 
C1 1.50 1.53 1.50  93.27 103.39 13.06  536.69 537.11 48.36 
C2 3.39 3.43 1.50  24.99 35.11 13.06  480.76 481.18 48.36 
C3 3.26 3.30 1.50  72.69 82.81 13.06  478.71 479.12 48.36 
C4 2.56 2.55 1.48  65.35 75.47 13.06  425.75 426.30 47.54 
C5 3.96 4.00 1.50  89.17 99.29 13.06  512.81 513.23 48.36 
DrugBank 1.63 1.44 2.57  67.09 71.82 41.47  310.34 310.32 91.93 
NCI Diversity 2.46 2.45 1.91   64.69 69.15 33.55   272.35 283.59 84.64 
MLSMR(3000) 2.80 2.72 1.59  80.47 81.41 33.30  401.47 395.19 102.14 
MLSMR(347480) 2.89 2.80 1.43  74.61 76.49 28.96  358.53 362.19 83.05 
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Table 2. Loadings for the six principal components of the property space 
 
Principal component PC1 PC2 PC3 PC4 PC5 PC6 
eigenvalue 2.172 2.071 0.736 0.642 0.286 0.094 
cumulative 
eigenvalue (%) 
36.192 70.709 82.97 93.677 98.440 100 
HBA 0.277 0.456 -0.659 0.273 -0.289 -0.351 
HBD 0.012 0.525 0.068 -0.795 -0.255 0.154 
RB 0.607 0.058 -0.038 -0.225 0.742 -0.159 
SlogP 0.398 -0.488 0.211 -0.251 -0.466 -0.527 
TPSA -0.0004 0.523 0.692 0.328 0.0140 -0.375 
MW 0.629 0.043 0.193 0.271 -0.289 0.639 
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Figure S1 Non-symmetry in nearest neighbor relationships. If molecule “m” in a compound collection 
“M” is the nearest neighbor of molecule “n” in a second compound collection “N”, this does not 
necessarily mean that molecule “n” is the nearest neighbor of “m”. 
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n1 
n2 
n1 is the nearest-neighbor (NN) of m1 
however, m1 is NOT the NN of n1: 
m2 is the NN of n1 
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Figure S2 Property space of 3 LoLs, 15 combinatorial libraries, drugs (gray), NCI diversity (pink) and 3000 
compounds from MLSMR selected at random (light blue). The first two PC account for 70.41% of the variance. 
The loadings are summarized in Table S5. Figures S2A, S2B and S2C show a comparison of the property space of 
MLSMR with each LoL. The left hand side of these figures shows the LoLs in one color and on the right hand side 
show, in different colors, each of the five combinatorial libraries within a LoL. The largest loadings for the first PC 
correspond to MW followed by RB. In contrast, the largest loadings for the second PC correspond to SlogP 
followed by TPSA and HBD. 
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Table S1. Building blocks used to enumerate the coombinatorial libraries. The name of the functionality is 
also indicated 
LoLA 
(10
3
 = 1000 
compounds per 
library) 
R1 = R2 = R3 (10 amino acids)  
Methyl  -  Boc-L-Ala  
Hydrogen  -  Boc-Gly  
S-Isobutyl  -  Boc-L-Leu  
S-Isopropyl  -  Boc-L-Val  
S-4-Hydroxybenzyl  -  Boc-L-Tyr(BrZ)  
S-Hydroxymethyl  -  Boc-D-Ser(Bzl)  
(S-S)-1-Hydroxyethyl  -  Boc-D-Thr(Bzl)  
S-Phenyl  -  Boc-L-Phenylglycine  
S-Propyl  -  Boc-L-Norvaline  
S-Cyclohexyl  -  Boc-L-Cyclohexylalanine  
   
LoLB 
(10
3
 = 1000 
compounds per 
library) 
R1 = R3 (10 carboxilic acids) R2 = (10 amino acids) 
Phenethyl  -  phenylacetic S-methyl  -  Boc-L-Ala 
Butyl  -  butyric Hydrogen  -  Boc-Gly 
Isobutyl  -  isobutyric S-isobutyl  -  Boc-L-Leu 
2-Methylbutyl  -  2 -methylbutyric S-isopropyl  -  Boc-L-Val 
3-Methylpentyl  -  3-methylvaleric S-4-hydroxybenzyl  -  Boc-L-Tyr(BrZ) 
4-Methyl-benzyl  -  p-toluic S-hydroxymethyl  -  Boc-D-Ser(Bzl) 
Cyclopently-methyl  -  cyclopentanecarboxylic (S-S)-1-hydroxyethyl  -  Boc-D-Thr(Bzl) 
Cyclohexyl-methyl  -  cyclohexanecarboxylic S-phenyl  -  Boc-L-Phenylglycine 
(2-Methyl-cyclopropyl)-methyl  -   
2-methylcyclopropanecarboxylic 
S-propyl  -  Boc-L-Norvaline 
Cyclobutyl-methyl   -   Cyclobutanecarboxylic S-cyclohexyl  -  Boc-L-Cyclohexylalanine 
   
LoLC 
(6 x 6 x 6 x 5  = 
1080 
compounds per 
library) 
R1 = R2 = R3 (6 amino acids) R4 (5 carboxilic acids) 
S-Methyl  -  Boc-L-Ala Butyl  -  butyric 
Hydrogen  -  Boc-Gly Isobutyl  -  Isobutyric 
S-isobutyl  -  Boc-L-Leu 2-Methylbutyl  -  2-methylbutyric 
S-isopropyl  -  Boc-L-Val 4-Methyl-benzyl  -  p-toluic 
S-hydroxymethyl  -  Boc-D-Ser(Bzl) Cyclopently-ethyl  -  cyclopentanecarboxylic 
S-phenyl  -  Boc-L-Phenylglycine  
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Table S2. Molecular properties profile of combinatorial libraries and other data sets 
Library Column Max Q3 Median Q1 Min Mean StdDev U95 L95 
LoLA 
LoLB 
LoLC 
HBA 8.000 5.000 4.000 3.000 2.000 3.856 1.350 3.877 3.835 
HBD 7.000 3.000 2.000 1.000 1.000 2.500 1.346 2.521 2.479 
RB 20.000 12.000 10.000 7.000 3.000 9.822 2.997 9.869 9.775 
SlogP 8.024 4.115 2.793 1.309 -5.014 2.622 1.980 2.653 2.591 
TPSA 159.510 98.470 85.930 65.350 21.750 80.465 29.076 80.924 80.006 
MW 683.853 487.781 437.761 384.657 196.258 435.184 75.875 436.383 433.986 
LoLA 
HBA 7.000 5.000 4.000 3.000 2.000 3.700 1.261 3.735 3.665 
HBD 7.000 4.000 3.000 2.000 2.000 3.300 1.127 3.331 3.269 
RB 9.000 7.000 6.000 5.000 3.000 6.300 1.213 6.334 6.266 
SlogP 5.213 2.228 1.131 -0.137 -5.014 1.017 1.703 1.064 0.970 
TPSA 159.510 114.950 98.470 71.000 30.540 91.607 29.418 92.422 90.792 
MW 572.618 402.451 360.546 324.381 196.258 363.304 57.558 364.899 361.709 
A1 
HBA 7.000 5.000 5.000 4.000 4.000 4.900 0.794 4.949 4.851 
HBD 5.000 3.000 3.000 2.000 2.000 2.900 0.794 2.949 2.851 
RB 9.000 7.000 6.000 5.000 3.000 6.300 1.213 6.375 6.225 
SlogP 2.750 0.438 -0.582 -1.657 -5.014 -0.634 1.471 -0.543 -0.725 
TPSA 159.510 119.050 119.050 98.820 98.820 117.027 16.065 118.023 116.031 
MW 572.618 436.468 402.451 366.462 254.246 402.069 52.705 405.336 398.803 
A2 
HBA 7.000 5.000 5.000 4.000 4.000 4.900 0.794 4.949 4.851 
HBD 5.000 3.000 3.000 2.000 2.000 2.900 0.794 2.949 2.851 
RB 9.000 7.000 6.000 5.000 3.000 6.300 1.213 6.375 6.225 
SlogP 4.643 2.332 1.311 0.236 -3.121 1.260 1.471 1.351 1.168 
TPSA 91.230 50.770 50.770 30.540 30.540 48.747 16.065 49.743 47.751 
MW 516.686 380.536 346.519 310.530 198.314 346.137 52.705 349.404 342.871 
A3 
HBA 5.000 3.000 3.000 2.000 2.000 2.900 0.794 2.949 2.851 
HBD 7.000 5.000 5.000 4.000 4.000 4.900 0.794 4.949 4.851 
RB 9.000 7.000 6.000 5.000 3.000 6.300 1.213 6.375 6.225 
SlogP 4.513 2.201 1.181 0.106 -3.251 1.129 1.471 1.220 1.038 
TPSA 138.930 98.470 98.470 78.240 78.240 96.447 16.065 97.443 95.451 
MW 514.630 378.480 344.463 308.474 196.258 344.081 52.705 347.348 340.815 
A4 
HBA 5.000 3.000 3.000 2.000 2.000 2.900 0.794 2.949 2.851 
HBD 5.000 3.000 3.000 2.000 2.000 2.900 0.794 2.949 2.851 
RB 9.000 7.000 6.000 5.000 3.000 6.300 1.213 6.375 6.225 
SlogP 4.884 2.572 1.551 0.476 -2.881 1.500 1.471 1.591 1.408 
TPSA 125.370 84.910 84.910 64.680 64.680 82.887 16.065 83.883 81.891 
MW 516.598 380.448 346.431 310.442 198.226 346.049 52.705 349.316 342.783 
A5 
HBA 5.000 3.000 3.000 2.000 2.000 2.900 0.794 2.949 2.851 
HBD 5.000 3.000 3.000 2.000 2.000 2.900 0.794 2.949 2.851 
RB 9.000 7.000 6.000 5.000 3.000 6.300 1.213 6.375 6.225 
SlogP 5.213 2.902 1.881 0.806 -2.551 1.829 1.471 1.921 1.738 
TPSA 155.410 114.950 114.950 94.720 94.720 112.927 16.065 113.923 111.931 
MW 548.732 412.582 378.565 342.576 230.360 378.183 52.705 381.450 374.917 
LoLB 
HBA 5.000 4.000 3.000 2.000 2.000 3.100 1.082 3.130 3.070 
HBD 4.000 2.000 1.000 1.000 1.000 1.700 0.922 1.726 1.674 
RB 15.000 12.000 11.000 10.000 9.000 11.100 1.179 11.133 11.067 
SlogP 7.117 4.879 3.985 2.953 -0.173 3.863 1.319 3.899 3.826 
TPSA 110.260 90.030 76.120 55.890 21.750 70.679 26.335 71.409 69.949 
MW 596.728 480.830 448.696 418.674 336.528 450.684 45.329 451.940 449.428 
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Table S2. (continued) 
B1 
HBA 5.000 5.000 4.000 4.000 4.000 4.300 0.459 4.328 4.272 
HBD 2.000 2.000 1.000 1.000 1.000 1.300 0.459 1.328 1.272 
RB 15.000 12.000 11.000 10.000 9.000 11.100 1.180 11.173 11.027 
SlogP 4.653 2.950 2.313 1.479 -0.173 2.212 1.001 2.274 2.150 
TPSA 110.260 110.260 90.030 90.030 90.030 96.099 9.275 96.674 95.524 
MW 596.728 515.215 488.673 462.635 394.516 489.449 38.969 491.864 487.034 
B2 
HBA 5.000 5.000 4.000 4.000 4.000 4.300 0.459 4.328 4.272 
HBD 2.000 2.000 1.000 1.000 1.000 1.300 0.459 1.328 1.272 
RB 15.000 12.000 11.000 10.000 9.000 11.100 1.180 11.173 11.027 
SlogP 6.547 4.843 4.207 3.373 1.721 4.106 1.001 4.168 4.044 
TPSA 41.980 41.980 21.750 21.750 21.750 27.819 9.275 28.394 27.244 
MW 540.796 459.283 432.741 406.703 338.584 433.517 38.969 435.932 431.102 
B3 
HBA 3.000 3.000 2.000 2.000 2.000 2.300 0.459 2.328 2.272 
HBD 4.000 4.000 3.000 3.000 3.000 3.300 0.459 3.328 3.272 
RB 15.000 12.000 11.000 10.000 9.000 11.100 1.180 11.173 11.027 
SlogP 6.417 4.713 4.077 3.242 1.591 3.975 1.001 4.037 3.913 
TPSA 89.680 89.680 69.450 69.450 69.450 75.519 9.275 76.094 74.944 
MW 538.740 457.227 430.685 404.647 336.528 431.461 38.969 433.876 429.046 
B4 
HBA 3.000 3.000 2.000 2.000 2.000 2.300 0.459 2.328 2.272 
HBD 2.000 2.000 1.000 1.000 1.000 1.300 0.459 1.328 1.272 
RB 15.000 12.000 11.000 10.000 9.000 11.100 1.180 11.173 11.027 
SlogP 6.787 5.083 4.447 3.613 1.961 4.346 1.001 4.408 4.284 
TPSA 76.120 76.120 55.890 55.890 55.890 61.959 9.275 62.534 61.384 
MW 540.708 459.195 432.653 406.615 338.496 433.429 38.969 435.844 431.014 
B5 
HBA 3.000 3.000 2.000 2.000 2.000 2.300 0.459 2.328 2.272 
HBD 2.000 2.000 1.000 1.000 1.000 1.300 0.459 1.328 1.272 
RB 15.000 12.000 11.000 10.000 9.000 11.100 1.180 11.173 11.027 
SlogP 7.117 5.413 4.777 3.942 2.291 4.675 1.001 4.737 4.613 
TPSA 106.160 106.160 85.930 85.930 85.930 91.999 9.275 92.574 91.424 
MW 572.842 491.329 464.787 438.749 370.630 465.563 38.969 467.978 463.148 
LoLC 
HBA 8.000 6.000 5.000 4.000 3.000 4.700 1.173 4.731 4.669 
HBD 7.000 4.000 2.000 1.000 1.000 2.500 1.420 2.538 2.462 
RB 20.000 13.000 11.000 10.000 8.000 11.900 2.379 11.963 11.837 
SlogP 8.024 4.198 2.981 1.794 -2.791 2.960 1.719 3.005 2.914 
TPSA 153.960 93.270 85.630 65.350 24.990 79.209 27.615 79.946 78.472 
MW 683.853 529.862 487.781 445.740 299.507 487.388 60.966 489.014 485.762 
C1 
HBA 8.000 6.000 5.000 5.000 5.000 5.500 0.646 5.539 5.461 
HBD 4.000 2.000 1.000 1.000 1.000 1.500 0.646 1.539 1.461 
RB 15.000 12.000 11.000 10.000 8.000 10.900 1.288 10.977 10.823 
SlogP 5.561 2.551 1.496 0.438 -2.791 1.532 1.499 1.621 1.442 
TPSA 153.960 113.500 93.270 93.270 93.270 103.385 13.064 104.164 102.606 
MW 683.853 569.747 536.694 505.693 407.515 537.112 48.356 539.996 534.228 
C2 
HBA 8.000 6.000 5.000 5.000 5.000 5.500 0.646 5.539 5.461 
HBD 4.000 2.000 1.000 1.000 1.000 1.500 0.646 1.539 1.461 
RB 15.000 12.000 11.000 10.000 8.000 10.900 1.288 10.977 10.823 
SlogP 7.454 4.444 3.389 2.332 -0.898 3.425 1.499 3.515 3.336 
TPSA 85.680 45.220 24.990 24.990 24.990 35.105 13.064 35.884 34.326 
MW 627.921 513.815 480.762 449.761 351.583 481.180 48.356 484.064 478.296 
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Table S2. (continued) 
C3 
HBA 6.000 4.000 3.000 3.000 3.000 3.500 0.646 3.539 3.461 
HBD 6.000 4.000 3.000 3.000 3.000 3.500 0.646 3.539 3.461 
RB 15.000 12.000 11.000 10.000 8.000 10.900 1.288 10.977 10.823 
SlogP 7.324 4.314 3.259 2.201 -1.028 3.295 1.499 3.384 3.205 
TPSA 133.380 92.920 72.690 72.690 72.690 82.805 13.064 83.584 82.026 
MW 625.865 511.759 478.706 447.705 349.527 479.124 48.356 482.008 476.240 
C4 
HBA 8.000 6.000 5.000 5.000 5.000 5.500 0.646 5.539 5.461 
HBD 7.000 5.000 4.000 4.000 4.000 4.500 0.646 4.539 4.461 
RB 20.000 17.000 16.000 15.000 13.000 15.900 1.288 15.977 15.823 
SlogP 6.269 3.591 2.560 1.533 -1.693 2.552 1.479 2.640 2.464 
TPSA 126.040 85.580 65.350 65.350 65.350 75.465 13.064 76.244 74.686 
MW 575.845 459.767 425.750 391.604 299.507 426.299 47.535 429.134 423.464 
C5 
HBA 6.000 4.000 3.000 3.000 3.000 3.500 0.646 3.539 3.461 
HBD 4.000 2.000 1.000 1.000 1.000 1.500 0.646 1.539 1.461 
RB 15.000 12.000 11.000 10.000 8.000 10.900 1.288 10.977 10.823 
SlogP 8.024 5.014 3.959 2.902 -0.328 3.995 1.499 4.084 3.906 
TPSA 149.860 109.400 89.170 89.170 89.170 99.285 13.064 100.064 98.506 
MW 659.967 545.861 512.808 481.807 383.629 513.226 48.356 516.110 510.342 
DrugBank 
HBA 11.000 3.000 2.000 1.000 0.000 2.460 1.686 2.546 2.375 
HBD 8.000 2.000 1.000 0.000 0.000 1.175 1.221 1.237 1.113 
RB 24.000 7.000 5.000 3.000 0.000 5.074 3.258 5.240 4.909 
SlogP 9.908 3.033 1.634 0.192 -13.609 1.442 2.571 1.572 1.311 
TPSA 266.490 97.530 67.085 40.460 0.000 71.819 41.471 73.924 69.713 
MW 537.576 376.776 310.336 246.078 75.067 310.324 91.933 314.992 305.656 
NCI 
HBA 12.000 3.000 2.000 2.000 0.000 2.695 1.635 2.770 2.620 
HBD 8.000 2.000 1.000 0.000 0.000 1.360 1.188 1.415 1.306 
RB 19.000 5.000 3.000 2.000 0.000 3.392 2.138 3.490 3.294 
SlogP 10.392 3.614 2.464 1.188 -3.342 2.452 1.908 2.539 2.365 
TPSA 214.110 87.157 64.690 46.530 0.000 69.148 33.550 70.685 67.612 
MW 696.129 328.544 272.348 224.262 114.108 283.589 84.642 287.465 279.713 
MLSMR 
(3000) 
HBA 18.000 5.000 4.000 3.000 0.000 3.721 1.820 3.786 3.656 
HBD 11.000 2.000 1.000 0.000 0.000 1.065 1.029 1.101 1.028 
RB 58.000 9.000 7.000 5.000 0.000 6.712 3.484 6.836 6.587 
SlogP 10.395 3.750 2.798 1.827 -4.562 2.715 1.594 2.772 2.658 
TPSA 356.010 98.770 80.470 60.912 0.000 81.410 33.302 82.601 80.218 
MW 1304.000 463.555 401.465 328.408 75.047 395.189 102.136 398.844 391.534 
MLSMR 
HBA 38.000 4.000 3.000 2.000 0.000 3.350 1.490 3.350 3.340 
HBD 38.000 2.000 1.000 0.000 0.000 1.074 0.901 1.077 1.071 
RB 143.00 8.00 6.00 4.00 0.00 6.161 2.896 6.171 6.151 
SlogP 25.738 3.728 2.889 1.966 -25.556 2.802 1.434 2.806 2.797 
TPSA 1470.000 93.210 74.610 57.120 0.000 76.490 28.960 76.586 76.393 
MW 3362.000 414.410 358.526 306.342 30.006 362.194 83.045 362.470 361.918 
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Table S3. Mean relative Tanimoto distance of drugs to combinatorial libraries in LTM plots 
LoL Library Distance Std 
LoLA A1 100.00 100.00 
 A2 106.57 287.25 
 A3 109.57 213.63 
 A4 102.78 147.69 
 A5 109.70 213.32 
LoLB B1 100.00 100.00 
 B2 108.31 206.65 
 B3 110.70 162.59 
 B4 103.61 144.50 
 B5 111.35 177.07 
LoLC C1 100.00 100.00 
 C2 107.60 202.91 
 C3 110.21 179.62 
 C4 109.93 201.73 
 C5 110.76 198.90 
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Table S4. Distribution of maximum and mean Tanimoto similarities of LoL to drugs, NCI diversity, and 
MLSMR using different structural representations 
 
Comparison with drugs (DrugBank) 
GpiDAPH3 
Library Max Q3 Median Q1 Min Mean Stdev U95 L95 
Maximum 
LoLA 0.654 0.504 0.471 0.433 0.290 0.466 0.052 0.468 0.465 
LoLB 0.620 0.553 0.528 0.497 0.405 0.524 0.041 0.525 0.522 
LoLC 0.603 0.504 0.478 0.452 0.340 0.478 0.044 0.479 0.477 
Mean 
LoLA 0.249 0.218 0.168 0.111 0.001 0.160 0.064 0.162 0.158 
LoLB 0.234 0.214 0.203 0.148 0.088 0.180 0.042 0.181 0.179 
LoLC 0.230 0.202 0.153 0.113 0.046 0.155 0.045 0.156 0.154 
 
piDAPH3 
Library Max Q3 Median Q1 Min Mean Stdev U95 L95 
Maximum 
LoLA 0.759 0.638 0.579 0.531 0.273 0.581 0.075 0.583 0.579 
LoLB 0.870 0.785 0.726 0.649 0.505 0.715 0.079 0.717 0.712 
LoLC 0.748 0.651 0.617 0.571 0.415 0.610 0.055 0.611 0.608 
Mean 
LoLA 0.330 0.287 0.229 0.160 0.000 0.216 0.080 0.219 0.214 
LoLB 0.352 0.309 0.288 0.203 0.109 0.258 0.064 0.260 0.257 
LoLC 0.330 0.289 0.202 0.158 0.039 0.217 0.068 0.218 0.215 
 
Comparison with NCI Diversity 
 
TGD 
Library Max Q3 Median Q1 Min Mean Stdev U95 L95 
Maximum 
LoLA 0.933 0.848 0.795 0.765 0.674 0.801 0.052 0.802 0.799 
LoLB 0.929 0.869 0.819 0.795 0.699 0.825 0.058 0.826 0.823 
LoLC 0.920 0.891 0.880 0.804 0.739 0.856 0.048 0.857 0.854 
Mean 
LoLA 0.561 0.539 0.518 0.499 0.455 0.519 0.026 0.519 0.518 
LoLB 0.537 0.519 0.502 0.489 0.460 0.502 0.020 0.503 0.501 
LoLC 0.536 0.512 0.500 0.491 0.473 0.502 0.015 0.502 0.502 
TGD 
Library Max Q3 Median Q1 Min Mean Stdev U95 L95 
Maximum 
LoLA 0.926 0.879 0.803 0.775 0.696 0.818 0.060 0.820 0.816 
LoLB 0.894 0.873 0.834 0.782 0.692 0.816 0.062 0.818 0.814 
LoLC 0.873 0.840 0.813 0.791 0.741 0.814 0.034 0.815 0.813 
Mean 
LoLA 0.633 0.598 0.563 0.530 0.475 0.564 0.039 0.565 0.563 
LoLB 0.587 0.560 0.539 0.505 0.481 0.533 0.029 0.534 0.533 
LoLC 0.588 0.551 0.533 0.505 0.481 0.531 0.027 0.532 0.530 
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Table S4. (continued) 
GpiDAPH3 
Library Max Q3 Median Q1 Min Mean Stdev U95 L95 
Maximum 
LoLA 0.708 0.514 0.466 0.420 0.221 0.464 0.068 0.466 0.462 
LoLB 0.645 0.543 0.494 0.427 0.335 0.489 0.070 0.491 0.487 
LoLC 0.543 0.448 0.415 0.388 0.306 0.419 0.043 0.420 0.418 
Mean 
LoLA 0.245 0.210 0.187 0.095 0.001 0.152 0.071 0.154 0.150 
LoLB 0.221 0.185 0.170 0.099 0.040 0.142 0.054 0.143 0.140 
LoLC 0.207 0.170 0.105 0.056 0.020 0.112 0.055 0.114 0.111 
 
 
 
Comparison with MLSMR 
MACCS 
Library Max Q3 Median Q1 Min Mean Stdev U95 L95 
Maximum 
LoLA 0.908 0.747 0.711 0.681 0.581 0.716 0.054 0.717 0.714 
LoLB 0.911 0.750 0.711 0.683 0.590 0.724 0.061 0.726 0.722 
LoLC 0.922 0.759 0.728 0.695 0.612 0.734 0.059 0.736 0.733 
Mean 
LoLA 0.469 0.435 0.403 0.374 0.320 0.403 0.035 0.404 0.402 
LoLB 0.480 0.430 0.391 0.362 0.319 0.394 0.039 0.396 0.393 
LoLC 0.490 0.410 0.381 0.362 0.312 0.390 0.041 0.391 0.389 
  
TGD 
Library Max Q3 Median Q1 Min Mean Stdev U95 L95 
Maximum 
LoLA 0.928 0.849 0.813 0.769 0.660 0.808 0.061 0.810 0.806 
LoLB 0.919 0.877 0.857 0.806 0.700 0.832 0.067 0.834 0.831 
LoLC 0.916 0.886 0.857 0.811 0.747 0.849 0.049 0.850 0.847 
Mean 
LoLA 0.694 0.635 0.606 0.514 0.393 0.583 0.074 0.585 0.581 
LoLB 0.683 0.670 0.624 0.537 0.519 0.609 0.062 0.611 0.607 
LoLC 0.697 0.648 0.612 0.519 0.481 0.593 0.070 0.594 0.591 
 
 
piDAPH3 
Library Max Q3 Median Q1 Min Mean Stdev U95 L95 
Maximum 
LoLA 0.778 0.625 0.569 0.521 0.000 0.574 0.074 0.576 0.572 
LoLB 0.831 0.767 0.713 0.602 0.458 0.687 0.091 0.690 0.685 
LoLC 0.728 0.623 0.584 0.548 0.406 0.583 0.055 0.585 0.582 
Mean 
LoLA 0.324 0.261 0.230 0.118 0.000 0.191 0.087 0.193 0.188 
LoLB 0.327 0.254 0.218 0.127 0.049 0.191 0.076 0.194 0.189 
LoLC 0.307 0.238 0.139 0.076 0.018 0.155 0.079 0.158 0.153 
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Table S4. (continued) 
GpiDAPH3 
Library Max Q3 Median Q1 Min Mean Stdev U95 L95 
Maximum 
LoLA 0.657 0.523 0.482 0.430 0.096 0.470 0.071 0.472 0.469 
LoLB 0.608 0.547 0.522 0.496 0.387 0.519 0.038 0.520 0.518 
LoLC 0.658 0.532 0.493 0.454 0.326 0.494 0.058 0.496 0.493 
Mean 
LoLA 0.294 0.253 0.220 0.091 0.000 0.178 0.088 0.180 0.175 
LoLB 0.281 0.246 0.230 0.124 0.051 0.188 0.071 0.190 0.186 
LoLC 0.268 0.231 0.139 0.080 0.029 0.152 0.073 0.154 0.150 
 
piDAPH3 
Library Max Q3 Median Q1 Min Mean Stdev U95 L95 
Maximum 
LoLA 0.798 0.665 0.612 0.550 0.000 0.604 0.086 0.606 0.602 
LoLB 0.802 0.719 0.688 0.644 0.514 0.679 0.052 0.681 0.678 
LoLC 0.764 0.676 0.631 0.584 0.406 0.626 0.065 0.628 0.624 
Mean 
LoLA 0.374 0.303 0.264 0.104 0.000 0.213 0.108 0.216 0.210 
LoLB 0.363 0.282 0.236 0.118 0.058 0.206 0.087 0.209 0.204 
LoLC 0.342 0.274 0.145 0.079 0.010 0.171 0.096 0.174 0.169 
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Table S5. Loadings for the six principal components of the property space of drugs, NCI diversity and MLSMR 
with 3000 compounds selected at random 
Principal component PC1 PC2 PC3 PC4 PC5 PC6 
eigenvalue 2.258 1.967 0.692 0.649 0.315 0.120 
cumulative eigenvalue (%) 37.629 70.417 81.947 92.757 98.006 100.000 
HBA -0.483 0.195 0.386 -0.626 0.313 0.301 
HBD -0.311 0.399 -0.794 -0.044 0.302 -0.144 
RB -0.513 -0.308 -0.263 -0.099 -0.709 0.246 
SlogP -0.033 -0.650 -0.211 0.182 0.523 0.474 
TPSA -0.348 0.411 0.241 0.723 8.5e-3 0.360 
MW -0.533 -0.341 0.222 0.204 0.185 -0.689 
 
 
